Health plan considerations for growing direct-to-consumer genetic testing
By Barbara Culley
17 August 2017
The growth in direct-to-consumer (DTC) genetic testing is driven by consumer awareness of the links between genetics and diseases, the evolution of patient empowerment, and precision medicine. This white paper looks at the progression of DTC genetic testing and the current demand and growth, discusses industry concerns, and suggests activities for health plans to consider.
About the Author(s)
Barbara Culley
Contact us
We’re here to help you break through complex challenges and achieve next-level success.
Health plan considerations for growing direct-to-consumer genetic testing
This white paper looks at the progression of direct-to-consumer genetic testing and the current demand and growth, discusses industry concerns, and suggests activities for health plans to consider.
Barbara Culley